ABBV-295
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
AbbVie · Phase 2 · Recruiting · Enrollment 360
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| ABBV-295 Arm 1 | n/r | n/r | n/r | n/r | n/r |
| ABBV-295 Arm 2 | n/r | n/r | n/r | n/r | n/r |
| ABBV-295 Arm 3 | n/r | n/r | n/r | n/r | n/r |
| ABBV-295 Arm 4 | n/r | n/r | n/r | n/r | n/r |
| ABBV-295 Arm 5 | n/r | n/r | n/r | n/r | n/r |
| ABBV-295 Arm 6 | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.